Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.

Symeres, a leading mid-sized transatlantic contract research development and manufacturing organization for drug discovery and development operating globally, has announced it has been awarded ISO/IEC ...

Semaglutide has already become more than just a “vanity drug.” Clinical trials like SUSTAIN-6 and FLOW have shown it can slash the risk of kidney disease, reduce major heart attacks, and even lower ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 12:30 PM EDTCompany ParticipantsNeil Kumar - Co-Founder, ...

The Contract Development and Manufacturing Organization (CDMO) industry in India is a fast-growing segment of the pharmaceutical sector that provides outsourced drug development and manufacturing ...

Leerink Global Healthcare Conference 2026 March 10, 2026 10:40 AM EDTCompany ParticipantsBrian Lian - President, CEO ...

BioDuro, a global CRDMO, has appointed Andrew Thomas, Ph.D., and Stevan Djuric, Ph.D., as scientific advisors.

Researchers developed a machine-learning workflow that predicts how chemical reactions will form specific “handed” versions of molecules—critical for safe and effective drugs. Trained on small ...

AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...

Details will be disclosed 11 March 2026 9 AM ET at 29th Annual TechConnect World Innovation Conference and Expo at ...